103 Jack Dinger Building – Suite 112
Tarek B. Eshak, MD, MPH, DrPH is an Assistant Professor of Public Health in the Department of public where he teaches epidemiology, biostatistics, introduction to study of diseases, and health service administration to both undergraduate and graduate students.
Prior to joining Slippery Rock University of Pennsylvania, Dr. Eshak was a post-doctoral fellow with Harrisburg University of Science and Technology (2021-2022) where he supported the planning and implementation of the State Health Improvement Plan (SHIP) project in Pennsylvania. Dr. Eshak also held a Research Assistant position with the Pennsylvania State University, College of Medicine, Department of Public Health Sciences (2018-2022) where he worked on evaluating the syndemic impact of substance abuse, depression, and diabetes on retention in care (RIC) among people living with HIV (PLHIV). He also studied the impact of the COVID-19 epidemic on RIC outcomes. Dr. Eshak holds a Bachelor of Medicine and Surgery (MBBCh. (MD)) from the Faculty of Medicine, Cairo University, Egypt where he has maintained his medical license with the Egyptian Medical Syndicate since 2002.
For almost 20 years, Dr. Eshak has been engaged in global health practice through an extensive working and living experiences across different settings around the world. Right after completing his Master of Public Health (MPH) degree from VU University in The Netherlands in 2011, Dr. Eshak started his international assignments as a public health advisor where he supported the development of HIV prevention, treatment, and care services across countries in the Middle-East and North Africa (MENA) and Central Asia. In addition, Dr. Eshak has a substantial experience leading public health programs with international development agencies such as WHO, GFATM, World Bank, USAID, FHI360, UNODC, and UNAIDS.
Presently, Dr. Eshak has a research focus on addressing the syndemic of infectious diseases, mental illness, and substance use disorders and examining their impact on health outcomes among vulnerable populations including PLHIV, adolescents, minority groups, and incarcerated populations.